Stock Price Quote

CONCORD BIOTECH LTD.

NSE : CONCORDBIOBSE : 543960ISIN CODE : INE338H01029Industry : Pharmaceuticals & DrugsHouse : Private
BSE1455.20-2.95 (-0.2 %)
PREV CLOSE ( ) 1458.15
OPEN PRICE ( ) 1460.00
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 5256
TODAY'S LOW / HIGH ( )1430.40 1483.40
52 WK LOW / HIGH ( )900 1711.95
NSE1459.20-0.9 (-0.06 %)
PREV CLOSE( ) 1460.10
OPEN PRICE ( ) 1462.10
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 1459.20 (821)
VOLUME 72431
TODAY'S LOW / HIGH( ) 1431.00 1490.00
52 WK LOW / HIGH ( )900.05 1725
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 1984
Management Info
Sudhir Vaid - Chairman Sudhir Vaid - Managing Director
Registered Office

Address 1482-86 ,Trasad Road,Dholka,
Ahmedabad,
Gujarat-382225

Phone 079-68138700

Email complianceofficer@concordbiotech.com

Website www.concordbiotech.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE

NEWS

21May Concord Biotech informs about earning
Pursuant to Regulation 30 of the SEBI (LODR) Regulation 2015, as amended..
17May Saudi Food and Drug Authority complete
Saudi Food and Drug Authority has successfully completed inspection of C..
15Apr Reply To Clarification Sought On Volu
We hereby submit that the company has disclosed all the material informa..
06Mar Concord Biotech informs about updates
In compliance with Regulation 30 of SEBI (Listing Obligations and Disclo..
23Feb Concord Biotech gets GMP for unit II o
Ministry of Health Pharmacy and Poisons Board, Republic of Kenya has com..

Financials

in Millions
QTR Dec 23 ANNUAL
Net Profit745.54
Gross Profit 1000.85
Operating Profit 1141.17
Net Sales

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Alkem Laboratories (BSE)
peergroup  5460.90 (2.86%)
M.Cap ( in Cr)65293.25
Glaxosmithkline Phar (BSE)
peergroup  2474.50 (4.09%)
M.Cap ( in Cr)41919.52
Gland Pharma (BSE)
peergroup  1880.90 (4.76%)
M.Cap ( in Cr)30980.40
Coral Laboratories (BSE)
peergroup  451.20 (20.00%)
M.Cap ( in Cr)161.20
Pfizer (BSE)
peergroup  4567.85 (1.64%)
M.Cap ( in Cr)20896.88

Shareholding Pattern

MUTUAL FUNDS/UTI 5.15%
PROMOTERS 44.08%
NON-INSTITUTION 41.03%
FI/BANKS/INSURANCE 2.88%
GOVERNMENT 0%
FII 0%

About Concord Biotech Ltd.

Concord Biotech Ltd. was incorporated in the year 1984. Its today's share price is 1455.2. Its current market capitalisation stands at Rs 15223.75 Cr. In the latest quarter, company has reported Gross Sales of Rs. 8531.68 Cr and Total Income of Rs.8884.78 Cr. The company's management includes Prakash Sajnani, Ankur Vaid, Sudhir Vaid, Sudhir Vaid.

It is listed on the BSE with a BSE Code of 543960 , NSE with an NSE Symbol of CONCORDBIO and ISIN of INE338H01029. It's Registered office is at 1482-86 ,Trasad Road,DholkaAhmedabad-382225, Gujarat. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are Deloitte Haskins & Sells, Deloittee Haskins & Sells

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.